Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Drug Free Solution's Enterprise Value is $0.11 Mil.
Drug Free Solution's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2014 was $-0.74 Mil. Therefore, Drug Free Solution's EV-to-OCF for today is -0.15.
The historical rank and industry rank for Drug Free Solution's EV-to-OCF or its related term are showing as below:
DSOL'
s EV-to-OCF Range Over the Past 10 Years
Min: -14.96 Med: 0 Max: 0
Current: -0.15
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Drug Free Solution (OTCPK:DSOL) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Drug Free Solution's PE Ratio (TTM) for today is calculated as:
Drug Free Solution's share price for today is $0.0004.
Drug Free Solution's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Drug Free Solution EV-to-OCF Related Terms
Drug Free Solution EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Drug Free Solution's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Drug Free Solution's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Drug Free Solution EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Drug Free Solution's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Drug Free Solution's EV-to-OCF falls into.
Drug Free Solution's current Enterprise Value is $0.11 Mil.
Drug Free Solution's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Drug Free Solution (DSOL) has a EV-to-OCF of -0.15 as of Aug. 10, 2026.
Is Drug Free Solution's EV-to-OCF too high?
Drug Free Solution's current EV-to-OCF is -0.15.
How does Drug Free Solution's EV-to-OCF compare to USEL and ZZLL?
Drug Free Solution's EV-to-OCF of -0.15 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-OCF is 8.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.95, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Drug Free Solution's current EV-to-OCF is -0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drug Free Solution stock overvalued right now?
Drug Free Solution (DSOL) has a current EV-to-OCF of -0.15. The current EV-to-OCF is -0.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Drug Free Solution (DSOL), the current EV-to-OCF is -0.15 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Drug Free Solution Inc is a United States based holding company that owns and operates various subsidiaries in the healthcare industry. It is focused on acquiring healthcare operations that focus on Home Healthcare, Developmental Disabilities, Hospice Care, Skilled Nursing, Residential Rehabilitation, Home & Community Based Services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSOL has been successfully added to your 
